Page last updated: 2024-10-25

ciclopirox and Hepatitis B Virus Infection

ciclopirox has been researched along with Hepatitis B Virus Infection in 1 studies

Research Excerpts

ExcerptRelevanceReference
"The Ciclopirox derivatives were ranked based on their free energy of binding (ΔGB)."5.91A fragment-based drug discovery developed on ciclopirox for inhibition of Hepatitis B virus core protein: An in silico study. ( Askari, FS; Ghorbanzadeh, T; Khalaj, F; Mohebbi, A; Naderifar, S; Sammak, AS, 2023)
"The Ciclopirox derivatives were ranked based on their free energy of binding (ΔGB)."1.91A fragment-based drug discovery developed on ciclopirox for inhibition of Hepatitis B virus core protein: An in silico study. ( Askari, FS; Ghorbanzadeh, T; Khalaj, F; Mohebbi, A; Naderifar, S; Sammak, AS, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Mohebbi, A1
Ghorbanzadeh, T1
Naderifar, S1
Khalaj, F1
Askari, FS1
Sammak, AS1

Other Studies

1 other study available for ciclopirox and Hepatitis B Virus Infection

ArticleYear
A fragment-based drug discovery developed on ciclopirox for inhibition of Hepatitis B virus core protein: An in silico study.
    PloS one, 2023, Volume: 18, Issue:5

    Topics: Antiviral Agents; Capsid Proteins; Ciclopirox; Drug Discovery; Hepatitis B; Hepatitis B virus; Human

2023